Objective: To evaluate whether oral supplementation with arginine affects the humoral and innate immune response after vaccination against Streptococcus pneumoniae in a group of people aged 60 y and older, free-living in the community. Design: A randomized controlled trial with one supplemented group and one control group. Setting: Older persons living in the community. Subjects: A total of 29 adults aged 60 y and older. Interventions: The older people were randomized into two groups, one with arginine supplementation (15 g/day) for 4 weeks after pneumococcal vaccine. The control group received only the vaccine. Anthropometric measurements and immune system function parameters: neutrophil chemotaxis and phagocytosis, natural killer cell activity, determination of serum pneumococcal polysaccharide antibodies and serum C3 and C4. Results: Neutrophil phagocytosis and the serum concentration of complement (C3 and C4) did not differ between groups. IgG antibodies against pneumococcal polysaccharide serotypes 1, 5 and 6B increased in both groups. The following parameters increased in the arginine-supplemented group compared to the nonsupplemented group: neutrophil chemotaxis (34 vs 19 units of migration, P ¼ 0.002), natural killer cell cytotoxicity (23.3 vs 13.4 10 M/Ul 40%, P ¼ 0.011) and IgG against antigen 5 (12.3 vs 6.2 mg/ml, P ¼ 0.044).
Introduction
Age-related changes in immune system function affect immune responses (Fossel, 2002; Urban et al, 2002) . These changes do not represent an even decrease in immune function but a complex and unequal immune system debilitation. The association of changes in the immune response with those of local defense mechanisms and the presence of comorbidities turn older persons more susceptible to infectious diseases (Bender, 2003) .
In spite of the remarkable improvement in diagnostic methods and the availability of new treatments for older subjects, hospitalizations and deaths due to infectious diseases are still relevant. Therefore, various methods for the prevention of infectious diseases have been proposed. Most interventions fall into one of two categories: (i) immunizations and (ii) measures for improvement of the immune response (Kirk et al, 1994) . Immunization against Streptococcus pneumoniae, although being formally recommended for all persons aged 65 y or over, still finds considerable opposition among clinicians and patients, mainly because it is not fully protective and because the immune response to pneumococcal antigens varies considerably (Jackson et al, 2003) .
Regarding measures for enhancement of the immune response, nutritional intervention is one of the methods most frequently employed for this purpose. The results of these measures are much less obvious and there is considerable controversy in the literature about their efficacy (Suchner et al, 2002) .
Some authors have shown that arginine intake improves the immune response, especially that dependent on T-cell activity, as shown by an increased response to concanavalin A, phytohemagglutinin and allogenic target cells (Efron & Barbul, 2000; Alexander, 2002; Muhling et al, 2002) . Although some experimental studies have suggested that the use of arginine as a supplement leads to clinical benefits in critically ill patients (Muhling et al, 2002; Lesourd, 2004) , there is a lack of studies about the potential benefits of any nutrients supplementation after pneumococcal immunization of older persons, free-living in the community. Considering the individual variation in the immune response to pneumococcal vaccine and the reported benefits of arginine supplementation for immune function, this study intended to verify whether or not oral arginine supplementation affects the humoral response against the pneumococcal polysaccharide vaccine and some variables of the innate immune response in a group of persons aged 60 y and older, living in the community. Since the S. pneumoniae serotypes 1, 3, 4, 5 and 6B have been reported to be the most prevalent pneumococcal disease in Brazil (Brandileone et al, 2003) , some of these pneumococcal antigens were evaluated.
Methods

Participants
Free-living volunteers from the Geriatric Medicine Outpatient Clinic of the University Hospital, Faculty of Medicine of Ribeirão Preto were studied. The files, including clinical history and laboratory tests, of each volunteer were reviewed and at the time of enrollment in this study, the volunteers were submitted to judicious clinical evaluation. Volunteers with acute infectious diseases, autoimmune disorders, diabetes mellitus, gastrointestinal disorders, malignant neoplasms, renal diseases, tobacco smoking, under treatment with corticosteroids and/or other immunosuppressive medications, taking amino-acid supplementation and previously immunized against pneumococcus were excluded from the study.
This research was approved by the local Ethics Committee and all volunteers gave written informed consent to participate.
Study protocol
Initially, all volunteers were submitted to medical and anthropometric evaluation and fasting blood samples were collected for the study of basal immune response (see below).
After the initial assessment, all volunteers were immunized with the pneumococcal polysaccharide vaccine (Pneumo 23 s , Pasteur Mérieux Connaught), with the following S. pneumoniae serotypes: 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F. Volunteers were allocated to two groups by random selection at the entry into the trial. Group A received arginine supplementation, 15 g/day, for 4 weeks and Group N received no arginine supplementation. Intake of the diet, which consisted primarily of rice, beans and red/white meat, provided closely similar amounts of total protein, energy, minerals and vitamins.
On the last day of the 4-week period, the anthropometric and immune response variables of all volunteers were reassessed as described below.
Anthropometric evaluation
The following anthropometric measurements were obtained for each volunteer: weight, height, body mass index, arm circumference, arm height, tricipital skinfold, muscle circumference of the arm and arm fat index (Vannucchi & Marchini, 1996) .
Immune system function variables Neutrophil chemotaxis assay: Neutrophil chemotaxis was calculated by the difference between the migration of neutrophils with and without endotoxin, expressed in micrometers as previously described (Donadi & Falcão, 1987) .
Natural killer cell activity: The activity of natural killer cells was studied using a cytotoxic assay, as previously described (Bryant et al, 1992) . Results were normalized by conversion to lytic units and are reported as the number of lytic units contained in 10 7 cells (Bryant et al, 1992) .
Stimulated NBT test:
The reduction of the nitroblue tetrazolium (NBT) dye was scored by counting 200 neutrophils using a Â 100 oil immersion objective with large blue deposits in the cytoplasm (Lace et al, 1975) .
Determination of serum antibodies against S. pneumoniae: IgG antibodies against S. pneumoniae 1, 5 and 6B antigens were determined by ELISA, as previously described (Lahood et al, 1993) . Antibody levels were quantitated based on a control curve constructed with a reference serum pool, substandardized against a standard developed by the Center for Disease Control and Prevention, USA.
Determination of serum C3 and C4 concentration: Serum concentrations of the complement components C3 and C4 (m g/dl) were determined by automated kinetic nephelometry (Immunochemistry analyzer ICS II -Beckman Instruments Inc., Diagnostic System Group, Galway, Ireland).
Statistical analysis
Nonparametric tests were applied for statistical analysis using the SPSS software, version 10.0. (SPSS Inc., Chicago, IL, USA). The Mann-Whitney test was used to perform comparisons between two independent groups and the Wilcoxon signed Ranks test was used to perform comparisons between two time points. Statistical significance was accepted at the 0.05 level.
Results
The 29 selected volunteers were randomly assigned to two groups as follows: Group A: 15 volunteers (six males) with a median age of 70 y. Group N: 14 volunteers (seven males) with a median age of 68.5 y. Intolerance to arginine, fever or cutaneous rash following vaccination was not observed. There were no significant differences in anthropometric data between Groups A and N (Table 1) . Anthropometric evaluation showed that all volunteers were healthy. Apart from tricipital skinfold and arm fat index in Group N, there were no significant changes in anthropometric measurements before and after the study. Table 2 shows the results of immunologic evaluation before and after the supplementation period. There were no differences in the baseline values of any measurements between Groups A and N.
Neutrophil chemotaxis: After the 4-week arginine supplementation period, neutrophil chemotaxis increased in the supplemented group (from 19 to 34 units of migration, P ¼ 0.005) and remained unchanged in the nonsupplemented group.
Cytotoxicity of natural killer cells: Cytotoxicity was increased in the supplemented group (13.4 vs 23.3, P ¼ 0.011) against baseline, but there was no difference between groups at the end of the study.
NBT, complement C3 and C4: No significant differences were observed.
After vaccination with pneumococcal polysaccharide, levels of IgG antibodies against serotype 1 (Group N ¼ 1.5 vs 4.3 mg/ml, P ¼ 0.001 and Group A ¼ 2.9 vs 5.9 mg/ml, P ¼ 0.0008), serotype 5 (Group N ¼ 2.4 vs 6.2 mg/ml, P ¼ 0.001 and Group A ¼ 3.8 vs 12.3 mg/ml, P ¼ 0.0007) and serotype 6B (Group N ¼ 3.1 vs 5.6 mg/ml, P ¼ 0.001 and Group A ¼ 2.2 vs 4.5 mg/ml, P ¼ 0.002) increased in both groups. With arginine supplementation, there was no increment of IgG antibodies against pneumococcal polysaccharide serotypes 1 (P ¼ 0.097) and 6B (P ¼ 0.981). However, the levels of IgG antibodies against serotype 5 were significantly Table 1 Characteristics of the subjects of groups N (nonsupplemented) and A (supplemented with arginine), at baseline and at the end of the study increased (6.2 vs 12.3 mg/ml, respectively, P ¼ 0.044) in the supplemented group.
Discussion
Stimulation of the immune system's components has been tried by many methods, all of them tentative and nonspecific (Provinciali et al, 1998; Schueren et al, 2001; Nieves & Langkamp-Henken, 2002) . Many age-related changes in the immune response have been described. The molecular and cellular bases for these changes are still unknown, but they may be related to changes in cellular transduction mechanisms (Burns, 2004) . As an example, arginine supplementation has been employed as a modulator of the cellular immune response. Sankilampi et al (1996) , suggest that an increment p1 mg/ ml in the absolute IgG-specific postimmunization levels is protective. Other authors suggest that immunization is successful when there is a two-fold increase of basal IgG levels (Go & Ballas, 1996) . According to these studies, immunization against serotypes 1, 5 and 6B in the present series of patients can be considered successful, independently of arginine supplementation.
In this study, arginine supplementation improved neutrophil chemotaxis, natural killer cell activity and levels of IgG antibody against pneumococcal polysaccharide 5. Neutrophil chemotaxis was increased, in agreement with data reported by Azzarà et al (1995) , who studied the effects of a combination of lysine and arginine (lysarginine) on the immune response of patients with recurrent infections.
The percentage of neutrophils that reduced NBT dye observed in the elderly patients of the present study, receiving arginine supplementation or not, was closely similar; however, it has been reported that elderly volunteers exhibit values that are significantly decreased in relation to those observed for healthy, younger adults (Corberand et al, 1981) .
Natural killer cell activity was enhanced by arginine supplementation. Arginine has been shown to improve natural killer cell activity in other studies and this effect is probably mediated by an enhancement of nitric oxidemediated pathways (Nieves & Langkamp-Henken, 2002) .
Arginine supplementation also increased the postimmunization plasma level of IgG antibody against pneumococcal polysaccharide serotype 5, with no significant effect on immunoglobulin levels against two other serotypes (1 and 6B). Although many studies have described the effects of arginine on immune response variables, high protein intake could have similar effects. This is always a doubt to be clarified, and this issue is still open to future investigation.
The clinical follow-up of immunized persons is another method for the evaluation of immunization efficacy (Koivula et al, 1997) , but a study with a higher number of volunteers and a longer period of follow-up would be necessary to assess this parameter. An important limitation of long periods of arginine supplementation is that high daily doses of arginine such as those employed in this and other studies are generally provided by arginine syrup, which was not well tolerated by the volunteers studied here. Thus, compliance with long periods of supplementation would not be expected. It is important to note that in this study a lower dose of arginine was employed, as compared with previous ones (15 vs 30 g/day), with similar results. Increased lymphocyte proliferation in response to mitogens and increased natural killer cell cytotoxicity have been reported for normal or breast cancer patients supplemented with arginine, 30 mg/day (Barbul et al, 1981; Brittenden et al, 1994) . If supplementation efficacy is maintained with even lower doses of arginine, longer studies may become more feasible and the possibility of supplementation with arginine for therapeutic purposes may become much more attractive. Anyway, further controlled studies are required to determine whether a basal dietary intake of arginine is required to maintain immune function during health and how much arginine is required to meet metabolic demand during periods of growth, in the presence of stress (Nieves & Langkamp-Henken, 2002) or during senescence.
In conclusion, this study suggests that 15 g/day arginine intake for older people increases neutrophil chemotaxis, natural killer cell cytotoxicity and the serum concentration of IgG antibodies against pneumococcal polysaccharide serotype 5, after pneumococcal vaccine. This supplementation may be useful to enhance the response to pneumococcal vaccine in selected elderly subgroups, that is, those patients prone to develop high-risk infections.
